4-carbamoylimidazolium 5-olate has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K; Miyazaki, T; Ogawa, M; Ohno, R; Ota, K; Sakai, Y; Suzuoki, Y; Uzuka, Y; Yamada, K; Yoshida, T | 1 |
| Saito, Y; Uzuka, Y | 1 |
| Fukui, M; Inaba, M; Morisada, S; Nakamura, M; Sakurai, Y; Tsukagoshi, S | 1 |
1 trial(s) available for 4-carbamoylimidazolium 5-olate and Lung Neoplasms
| Article | Year |
|---|---|
[Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].
Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Evaluation; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Purines | 1989 |
2 other study(ies) available for 4-carbamoylimidazolium 5-olate and Lung Neoplasms
| Article | Year |
|---|---|
[SM-108].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cell Line; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imidazoles; Leukemia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1985 |
[Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Drug Administration Schedule; Imidazoles; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Sarcoma 180 | 1985 |